Уноси

Основе фармакокинетике са биофармацијом (2014)

М. Миков, С. Голочорбин Кон, Д. Бокоњић, В. Драгојевић-Симић, Е. Шаркиновић, А. Ковачевић, С. Гигов, В. Топић, Н. Ранчић, Основе фармакокинетике са биофармацијом, Ortomedics book, Novi Sad, 2014
Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach (2018-05)

В. Топић Вученовић, Z. Rajkovača, D. Jelić, D. Stanimirović, G. Vuleta, B. Miljković, K. Vučićević, Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 74, No. 8, pp. 1037 - 1045, May, 2018
Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics) (2018-12)

S. Vezmar Kovačević, K. Vučićević, V. Topić Vučenović, Z. Rajkovača, B. Miljković, Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics), Arhiv za farmaciju, Vol. 68, No. 6, pp. 1071 - 1083, Dec, 2018
Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice (2021-08)

M. Roganović, A. Homšek, M. Jovanović, V. Topić Vučenović, M. Ćulafić, B. Miljković, K. Vučićević, Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice, Arhiv za farmaciju, Vol. 71, No. 4, pp. 336 - 353, Aug, 2021
Population exposure-response model of 131I in patients with benign thyroid disease (2021-10)

V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, Population exposure-response model of 131I in patients with benign thyroid disease, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 165, pp. 105942 - 105942, Oct, 2021
Ispitivanje sadržaja fluorida u komercijalno dostupnim pastama za zube upotrebom fluoridne jon-selektivne elektrode (2015)

N. Umićević, M. Krivokuća, V. Topić Vučenović, D. Jelić, Ispitivanje sadržaja fluorida u komercijalno dostupnim pastama za zube upotrebom fluoridne jon-selektivne elektrode, Zbornik sažetaka radova. III Kongres farmaceuta Bosne i Hercegovine sa međunarodnim učešćem. Sarajevo, 2015, pp. 181 - 182, 2015
Prediction of the radioiodine therapy outcomes in patients with benign thyroid disease based on pre-therapeutic dosimetry (2018-09)

V. Topić Vučenović, D. Jelić, Z. Rajkovača, B. Miljković, K. Vučićević, Prediction of the radioiodine therapy outcomes in patients with benign thyroid disease based on pre-therapeutic dosimetry, Kongres nuklearne medicine Srbije sa međunarodnim učešćem 2018, Program i zbornik sažetaka, pp. 135 - 135, Sep, 2018
Investigation of the influence of functional thyroid volume on the probability of 131I therapy outcome in patients with benign thyroid disease (2018-10)

V. Topić Vučenović, Investigation of the influence of functional thyroid volume on the probability of 131I therapy outcome in patients with benign thyroid disease, Arhiv za farmaciju, 68, 75 - 368, pp. 360 - 361, Oct, 2018
Phytosynthesis of TiO2 nanoparticles for biomedical use: Antimicrobial and pharmacodynamics aspect (2019-10)

V. Antunović, A. Šmitran, R. Suručić, V. Topić Vučenović, N. Umićević, LJ. Suručić, D. Jelić, Phytosynthesis of TiO2 nanoparticles for biomedical use: Antimicrobial and pharmacodynamics aspect, 4. kongres farmaceuta u Bosni i Hercegovini sa međunarodnim učešćem. Knjiga sažetaka, Sarajevo 10-13. oktobar 2019, Oct, 2019
The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach (2021-01)

V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach, https://www.paganz.org/abstracts/the-influence-of-biologically-effective-dose-bed-on-the-131i-therapy-response-in-patients-with-benign-thyroid-disease-nonlinear-mixed-effect-modelling-approach/, Jan, 2021
Projekat “Sinteza, fizičko-hemijska karakterizacija, kvantitativni odnosi između strukture i dejstva, dizajn, tehnološka i farmaceutska analiza farmakološki aktivnih supstanci” broj 19/6-020/961 – 169/14 (2014)

V. Topić Vučenović, Projekat “Sinteza, fizičko-hemijska karakterizacija, kvantitativni odnosi između strukture i dejstva, dizajn, tehnološka i farmaceutska analiza farmakološki aktivnih supstanci” broj 19/6-020/961 – 169/14, 2014
Projekat “Fitosinteza, karakterizacija i biomedicinska primjena metalnih (Ag, Si, Cu) i oksidnih (ZnO, TiO2, CuO, Fe2O3) nanočestica: mikrobiološki, biokinetički i toksikološki aspekt ” (br. projekta 19/6-020/961 – 74/18) (2019)

V. Topić Vučenović, Projekat “Fitosinteza, karakterizacija i biomedicinska primjena metalnih (Ag, Si, Cu) i oksidnih (ZnO, TiO2, CuO, Fe2O3) nanočestica: mikrobiološki, biokinetički i toksikološki aspekt ” (br. projekta 19/6-020/961 – 74/18), 2019

Уноси

Основе фармакокинетике са биофармацијом (2014)

Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach (2018-05)

Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics) (2018-12)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice (2021-08)

Population exposure-response model of 131I in patients with benign thyroid disease (2021-10)

Ispitivanje sadržaja fluorida u komercijalno dostupnim pastama za zube upotrebom fluoridne jon-selektivne elektrode (2015)

Prediction of the radioiodine therapy outcomes in patients with benign thyroid disease based on pre-therapeutic dosimetry (2018-09)

Investigation of the influence of functional thyroid volume on the probability of 131I therapy outcome in patients with benign thyroid disease (2018-10)

Phytosynthesis of TiO2 nanoparticles for biomedical use: Antimicrobial and pharmacodynamics aspect (2019-10)

The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach (2021-01)

Projekat “Sinteza, fizičko-hemijska karakterizacija, kvantitativni odnosi između strukture i dejstva, dizajn, tehnološka i farmaceutska analiza farmakološki aktivnih supstanci” broj 19/6-020/961 – 169/14 (2014)

Projekat “Fitosinteza, karakterizacija i biomedicinska primjena metalnih (Ag, Si, Cu) i oksidnih (ZnO, TiO2, CuO, Fe2O3) nanočestica: mikrobiološki, biokinetički i toksikološki aspekt ” (br. projekta 19/6-020/961 – 74/18) (2019)